Triple-E T InnovatorThis page contains information on Triple-E T Innovator for veterinary use.
The information provided typically includes the following:
- Triple-E T Innovator Indications
- Warnings and cautions for Triple-E T Innovator
- Direction and dosage information for Triple-E T Innovator
Triple-E T InnovatorThis treatment applies to the following species:
Eastern & Western & Venezuelan, Killed Virus
Triple-E T Innovator Indications
For intramuscular vaccination of healthy horses 10 months of age and older as an aid in the prevention of equine encephalomyelitis due to Eastern, Western and Venezuelan viruses, and tetanus.
Dosage and AdministrationHorses, inject one 1 mL dose intramuscularly using aseptic technique. Administer a second 1 mL dose 3 to 4 weeks after the first dose. A 1 mL booster dose should be given annually. Early revaccination may be advisable when horses are faced with an outbreak or with other conditions which might make heavy exposure likely.
Triple-E T Innovator Caution
Store in the dark at 2° to 7°C (35° to 45°F). AVOID FREEZING. SHAKE WELL. Use entire contents when first opened. In some instances, transient local reactions may occur at the injection site. Do not vaccinate within 21 days before slaughter. In case of anaphylactoid reaction, administer epinephrine.
Thimerosal, neomycin and polymyxin B added as preservatives.
For Veterinary Use Only
Remove serial number and expiration date label and place on the animal’s medical chart.
U.S. Vet. License No. 190
Zoetis Inc., Kalamazoo, MI 49007, USA
NAC No.: 3690337.3
333 PORTAGE STREET, KALAMAZOO, MI, 49007
|Every effort has been made to ensure the accuracy of the Triple-E T Innovator information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.|
Copyright © 2017 North American Compendiums. Updated: 2017-02-06